PrioNet funds unique research collaboration

Guest Contributor
July 30, 2010

PrioNet Canada is funding a unique collaboration of academic and industry researchers to develop vaccines for prion disease that may also generate effective therapies for common cancers. Funded through PrioNet's Bootstrap program, the research will explore certain regions within prion proteins (epitopes) that may be ideal targets for developing vaccines. The project is led by PrioNet scientific director Dr Neil Cashman in conjunction with Dr Dawn Waterhouse (BC Cancer Agency) and Dr Yuzhuo Wang (BC Cancer Agency and Vancouver Prostate Centre). The industry partner is Amorfix Life Sciences Ltd and PREVENT - Pan Provincial Vaccine Initiative is the institutional partner....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.